This
page
is
part
of
the
FHIR
Specification
(v4.3.0:
R4B
(v5.0.0:
R5
-
STU
).
The
This
is
the
current
published
version
which
supercedes
in
it's
permanent
home
(it
will
always
be
available
at
this
version
is
5.0.0
.
URL).
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R5
R4B
R4
R3
Patient
Care
Work
Group
|
Maturity Level : 1 | Draft | Use Context : Country: World, Not Intended for Production use |
Official
URL
:
http://hl7.org/fhir/ValueSet/adverse-event-causality-assess
|
|
|||
| draft as of 2020-12-28 |
|
|||
|
|
|
|||
This value set is used in the following places:
Codes for the assessment of whether the entity caused the event.
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess
This
expansion
generated
28
May
2022
26
Mar
2023
This value set contains 6 concepts
Expansion
based
on
AdverseEventCausalityAssessment
v4.3.0
v0.1.0
(CodeSystem)
All
codes
in
this
table
are
from
the
system
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess
| Code | System | Display | Definition |
|
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess | Certain |
i) Event or laboratory test abnormality, with plausible time relationship to drug intake; ii) Cannot be explained by disease or other drugs; iii) Response to withdrawal plausible (pharmacologically, pathologically); iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon); or v) Re-challenge satisfactory, if necessary. |
|
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess | Probably/Likely |
i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Unlikely to be attributed to disease or other drugs; iii) Response to withdrawal clinically reasonable; or iv) Re-challenge not required. |
|
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess | Possible |
i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Could also be explained by disease or other drugs; or iii) Information on drug withdrawal may be lacking or unclear. |
|
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess | Unlikely |
i) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible); or ii) Disease or other drugs provide plausible explanations. |
|
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess | Conditional/Classified |
i) Event or laboratory test abnormality; ii) More data for proper assessment needed; or iii) Additional data under examination. |
|
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess | Unassessable/Unclassifiable |
i) Report suggesting an adverse reaction; ii) Cannot be judged because information is insufficient or contradictory; or iii) Data cannot be supplemented or verified. |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |